Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > 👀Fud Before no sales &now there been essentially no sales😉
View:
Post by jopatclo on Nov 13, 2024 10:18am

👀Fud Before no sales &now there been essentially no sales😉

Interesting  positif the vulture GranhamB mec no shares Ventripoint . See before no sales & now  ( It will be interesting to see if they have been able to get any sales....there been essentially no sales ) 
-CardioLogic Ltd Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of cardiac MRI.
With its new capabilities, Ventripoint 4.0 provides additional insights, including: 
-3D Tensors: Visualise the direction and magnitude of surface changes.
-4D Motion: Simulate a dynamic heart model across the cardiac cycle.
-3D Global Strain: Assess longitudinal, circumferential, and total surface area changes.
-3D Heat Map: Visualise surface area changes in a new heat map view.
-3D Segmentation: Access a detailed polar map for surface area change analysis.
- Now That V4.0 Europe V4.0 ok & Canada -The BEST automation and analysis of the PLANET GEN3EHO   https://ascendcv.com/ (Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients.)
- I think they know more about the Ventripoint tech than the whiners on this board. Something could happen anytime real fast!
FDA 4.0 It will happen, but not in a way we originally hoped. No investor is happy with the current outcome. You either wait or move on.
- Dr. Adams is a visionary with Ventripoint FDA V4.0 and Sales at any time now Insiders know!
https://ascendcv.com/ #vpt, and Remember
Clik integrations and see Seamless, flexible integration with heterogeneous AI, imaging and enterprise IT environments enables a best-of breed approach. Examples include:
  • Us2.ai - Benefit from the the industry’s most sophisticated integration of Us2.ai.
    • Us2.ai FDA-approved measurements feed ASE-validated suggested interpretations that can automatically complete the echo report 
    • Save time with single-click navigation to the automated measurement source frame 
    • 1-click sync to automated measurement frame
    • Distinct review processes for FDA-cleared versus investigational measurements, enhancing compliance and clarity 
    • Automatic grouping of Us2.ai measurements accelerates the measurement review process 
    • Visual notification of user edits performed on Us2.ai measurements promotes transparency and traceability 
  • Engineered for seamless integrationGen3Echo was designed with commitment to openness, seamlessly integrating with AI, ML, and advanced visualization software to foster innovation and collaboration. 
    • Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patientsVentripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels of accuracy. It can be used with all ultrasound systems supported by regulatory market approvals and is seamlessly integrated into the reading workflow enhancing diagnostic precision and treatment planning, ultimately improving the quality of pediatric care.
Comment by jopatclo on Nov 13, 2024 11:03am
GranhamB the vulture see Ventripoint Diagnostics Ltd.'s next-gen cardiac imaging system has been approved for use in EU and Canada (FDA reviewing). It provides more accurate cardiac output data for echo images. Automated, fast and easy to integrate into workflows. Existing users include Duke, Sick Kids, Seattle Children's, Vienna Children's, East Midlands, Evalina and German ...more  
Comment by jopatclo on Nov 13, 2024 12:59pm
GranhamB Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients.  Now 4.0 Europe & Canada $$$& Now @Bob123 CardioLogic Ltd Introducing Ventripoint 4.0! Ventripoint is ...more  
Comment by GrahamB on Nov 13, 2024 1:25pm
Jopatchie says" cardiac MRI. The BEST automation and analysis of the PLANET GEN3EHO   https://ascendcv.com/ Fud Before no sales &now there been essentially no sales" What you say is FUD is Facts Uncover Deceit  Of what I say is untrue-PROVE IT There have been no significant sales-only 30,000-50000 on millions of costs  The question is :If this is as you say ...more  
Comment by Pandora on Nov 14, 2024 12:33am
The news about the advancement of VMS+ 4.0 keeps getting better but the price keeps dropping. Bounced off the 52 week Low again. Is someone keeping it low for a purpose? Big outfits like GE and Ascend, if they were so inclined, could buy it for a steal. At 14 cents they could buy it at 28c and brag about a 100% increase. Of all the systems that are supposedly in the field now, were they all given ...more  
Comment by jopatclo on Nov 14, 2024 8:31am
Good news this morning Pandora the negative shows this to your great friend the vulture GranhamB. who has been mad at Ventripoint for years...probably a guy who was shown the door to Ventripoint :-) We at rock bottom now. A turn around and the 'climb' should be starting soon. Good time to get in.3..... 2.... 1.... 0.... Launch! $$$ Dr. Adams is a visionary with Ventripoint.I think they ...more  
Comment by G1945V on Nov 14, 2024 6:40am
Graham, it sure looks like Jopat got your goat. Where are you going with all of this nonsense? Quit while you're ahead and preserve some self-respect. You really got it in for Ventripoint. The only conclusion I can make of your disdain for it is that you must have dropped a bundle on it years back and it's your mission to see it fail. :) G1945V
Comment by jopatclo on Nov 14, 2024 9:17am
GranhamB the vulture good comment You really got it in for Ventripoint. The only conclusion I can make of your disdain for it is that you must have dropped a bundle on it years back and it's your mission to see it fail. :) see   I feel and believe we have at least a 10 bagger here and just a hunch but i think a lot of the recent sentiment turned "Fud" is just ...more  
Comment by jopatclo on Nov 13, 2024 2:04pm
GranhamB the vulture see  Interesting on Linkedin Hannah Crane Clinical Applications Specialist & Cardiac Sonographer Ventripoint Diagnostics Ltd. Likes this (Us2.ai has a feature that leverages the speed of our AI) post Seth Koeppel .Business Development 22h • Was chatting with some #echo enthusiasts recently and realized I should share a very useful and powerful application of #AI ...more